Laboratory-developed tests in the New European Union 2017/746 Regulation: opportunities and risks
In vitro diagnostics (IVD) in the European Union (EU) is facing fundamental change with the implementation of a new regulation termed in vitro diagnostic medical device regulation (IVDR) (1). Going into full effect in May 2022, IVDR will affect 447 million people in 27 countries. There is substantia...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2022
|
| In: |
Clinical chemistry
Year: 2022, Jahrgang: 68, Heft: 1, Pages: 40-42 |
| ISSN: | 1530-8561 |
| DOI: | 10.1093/clinchem/hvab215 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/clinchem/hvab215
|
| Verfasserangaben: | Michael Vogeser, Monika Brüggemann, Jochen Lennerz, Albrecht Stenzinger, and Ulrich M. Gassner |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1794976981 | ||
| 003 | DE-627 | ||
| 005 | 20230426072121.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220308s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/clinchem/hvab215 |2 doi | |
| 035 | |a (DE-627)1794976981 | ||
| 035 | |a (DE-599)KXP1794976981 | ||
| 035 | |a (OCoLC)1341445864 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Vogeser, Michael |e VerfasserIn |0 (DE-588)113475780 |0 (DE-627)522693385 |0 (DE-576)289764041 |4 aut | |
| 245 | 1 | 0 | |a Laboratory-developed tests in the New European Union 2017/746 Regulation |b opportunities and risks |c Michael Vogeser, Monika Brüggemann, Jochen Lennerz, Albrecht Stenzinger, and Ulrich M. Gassner |
| 264 | 1 | |c 2022 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Accepted September 21, 2021 | ||
| 500 | |a Gesehen am 08.03.2022 | ||
| 520 | |a In vitro diagnostics (IVD) in the European Union (EU) is facing fundamental change with the implementation of a new regulation termed in vitro diagnostic medical device regulation (IVDR) (1). Going into full effect in May 2022, IVDR will affect 447 million people in 27 countries. There is substantial concern that IVDR will result in over-regulation and potentially result in “the end of the laboratory-developed tests as we know it” (2).In this context, it should be noted that in the USA, the topic of regulation of in-house procedures—and in particular potential regulation of medical practice—has been a subject of controversy for a considerable time and a definitive conclusion is still pending (3-6). | ||
| 700 | 1 | |a Brüggemann, Monika |d 1968- |e VerfasserIn |0 (DE-588)173026753 |0 (DE-627)697951596 |0 (DE-576)133879666 |4 aut | |
| 700 | 1 | |a Lennerz, Jochen K. |d 1974- |e VerfasserIn |0 (DE-588)13368038X |0 (DE-627)550687572 |0 (DE-576)300020848 |4 aut | |
| 700 | 1 | |a Stenzinger, Albrecht |e VerfasserIn |0 (DE-588)139606106 |0 (DE-627)703395238 |0 (DE-576)312432755 |4 aut | |
| 700 | 1 | |a Gassner, Ulrich M. |d 1957- |e VerfasserIn |0 (DE-588)120798441 |0 (DE-627)080893473 |0 (DE-576)173365922 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical chemistry |d Washington, DC : American Association for Clinical Chemistry, 1955 |g 68(2022), 1, Seite 40-42 |h Online-Ressource |w (DE-627)266883117 |w (DE-600)1468161-4 |w (DE-576)075146401 |x 1530-8561 |7 nnas |a Laboratory-developed tests in the New European Union 2017/746 Regulation opportunities and risks |
| 773 | 1 | 8 | |g volume:68 |g year:2022 |g number:1 |g pages:40-42 |g extent:3 |a Laboratory-developed tests in the New European Union 2017/746 Regulation opportunities and risks |
| 856 | 4 | 0 | |u https://doi.org/10.1093/clinchem/hvab215 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220308 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 139606106 |a Stenzinger, Albrecht |m 139606106:Stenzinger, Albrecht |d 910000 |d 912000 |e 910000PS139606106 |e 912000PS139606106 |k 0/910000/ |k 1/910000/912000/ |p 4 | ||
| 999 | |a KXP-PPN1794976981 |e 4082741119 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"2022","dateIssuedKey":"2022"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"3 S."}],"id":{"eki":["1794976981"],"doi":["10.1093/clinchem/hvab215"]},"name":{"displayForm":["Michael Vogeser, Monika Brüggemann, Jochen Lennerz, Albrecht Stenzinger, and Ulrich M. Gassner"]},"person":[{"given":"Michael","role":"aut","family":"Vogeser","display":"Vogeser, Michael"},{"role":"aut","given":"Monika","display":"Brüggemann, Monika","family":"Brüggemann"},{"display":"Lennerz, Jochen K.","family":"Lennerz","role":"aut","given":"Jochen K."},{"role":"aut","given":"Albrecht","display":"Stenzinger, Albrecht","family":"Stenzinger"},{"given":"Ulrich M.","role":"aut","family":"Gassner","display":"Gassner, Ulrich M."}],"relHost":[{"disp":"Laboratory-developed tests in the New European Union 2017/746 Regulation opportunities and risksClinical chemistry","origin":[{"publisherPlace":"Washington, DC ; Oxford","dateIssuedKey":"1955","dateIssuedDisp":"1955-","publisher":"American Association for Clinical Chemistry ; Oxford University Press"}],"part":{"year":"2022","extent":"3","pages":"40-42","issue":"1","text":"68(2022), 1, Seite 40-42","volume":"68"},"pubHistory":["1.1955 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"266883117","language":["eng"],"note":["Gesehen am 26.08.2021"],"title":[{"title":"Clinical chemistry","title_sort":"Clinical chemistry","subtitle":"journal of the American Association for Clinical Chemistry ; international journal of laboratory medicine and molecular diagnostics"}],"id":{"issn":["1530-8561"],"zdb":["1468161-4"],"eki":["266883117"]},"corporate":[{"role":"isb","display":"American Association of Clinical Chemists"}]}],"recId":"1794976981","language":["eng"],"title":[{"title":"Laboratory-developed tests in the New European Union 2017/746 Regulation","subtitle":"opportunities and risks","title_sort":"Laboratory-developed tests in the New European Union 2017/746 Regulation"}],"note":["Accepted September 21, 2021","Gesehen am 08.03.2022"]} | ||
| SRT | |a VOGESERMICLABORATORY2022 | ||